Satralizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Monoclonal antibody Orphan drug Therapeutic monoclonal antibody Drug granted breakthrough therapy designation
rdfs:label	Satralizumab
owl:sameAs	dbr:Satralizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Chugai_Pharmaceutical_Co. http://en.wikipedia.org/wiki/Neuromyelitis_optica_spectrum_disorder
skos:prefLabel	Satralizumab
skos:altLabel	satralizumab
clgo:alternativeName	Enspryng
clgo:casNumber	1535963-91-7
clgo:drugbank	DB15762
clgo:fdaUniiCode	YB18NF020M
clgo:kegg	D11079

About: clgr:Satralizumab